Oral Medications - 23/08/14
Résumé |
Primary hyperhidrosis commonly affects the axillae, palms, soles, scalp, face, and groin. Patients may have multiple areas involved making localized therapy challenging. Systemic therapy may be necessary and can be used as monotherapy or combined with other hyperhidrosis treatments for optimal outcomes. Systemic therapy can also be used to treat secondary hyperhidrosis and compensatory hyperhidrosis.
Le texte complet de cet article est disponible en PDF.Keywords : Systemic therapy, Anticholinergic, β-blocker, Glycopyrrolate, Oxybutynin, Propanolol, Clonidine, Hyperhidrosis
Plan
| Disclosure: D.A. Glaser has served as advisor for Allergan, Galderma, Miramar Labs, and Unilever. She has been an investigator and received research grants from Allergan, Miramar Labs, and Ulthera. |
Vol 32 - N° 4
P. 527-532 - octobre 2014 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?

